Joaquín
Casal Rubio
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (9)
2020
-
PD-(L)1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: A pairwise meta-analysis
Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-13
2018
-
Real world data of nivolumab for previously treated non-small cell lung cancer patients: A Galician lung cancer group clinical experience
Translational Lung Cancer Research, Vol. 7, Núm. 3, pp. 404-415
2016
-
EGFR testing and clinical management of advanced NSCLC: A galician lung cancer group study (GGCP 048-10)
Cancer Management and Research, Vol. 8, pp. 11-20
2015
-
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
Cancer Chemotherapy and Pharmacology, Vol. 76, Núm. 4, pp. 731-737
2014
-
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): A Galician Lung Cancer Group (GGCP) study
Cancer Chemotherapy and Pharmacology, Vol. 73, Núm. 3, pp. 451-457
2013
-
Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer
Journal of Geriatric Oncology, Vol. 4, Núm. 2, pp. 114-121
2012
-
First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients
Expert Opinion on Pharmacotherapy, Vol. 13, Núm. 10, pp. 1389-1396